Wednesday Morning Movers
January 07, 2015 at 09:17 AM EST
Galectin Therapeutics (NASDAQ: GALT) +53% - Wednesday morning, the company announced positive results from the Phase 1 trial of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.